Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04978753
Brief Title: the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer

First Submitted : July 20, 2021
First Submitted that Met QC Criteria : July 20, 2021
First Posted : July 27, 2021

Last Update Submitted that Met QC Criteria : July 20, 2021
Last Update Posted : July 27, 2021